Analyst Sets Lofty Goal For Corbus Pharmaceuticals Stock

Canaccord Genuity is bullish on the recent Corbus-Kaken collab

Managing Editor
Jan 11, 2019 at 9:18 AM
facebook X logo linkedin


The shares of Corbus Pharmaceuticals Holdings Inc (NASDAQ:CRBP) are up 1% to trade at $7.86 today, after Canaccord Genuity raised its price target on the drugmaker to $38 from $36 while maintaining its "overweight" rating. The analyst in coverage is bullish on Corbus Pharmaceuticals' recent pact with Kaken Pharmaceutical to develop lenabasum, a drug for systemic sclerosis and dermatomyositis. 

CRBP has only turned in one negative session in 2019 thus far, and is on track for its third straight weekly win of 10% or more. Heading into today, though, the drug stock was still trading below its 12-month breakeven point. That hasn't stopped all seven of brokerages in coverage from rating the equity a "buy" or better, including a bull note late in 2018. 

Short sellers are starting to head for the exits. Short interest fell by 5.5% in the last two reporting periods to 13.35 million shares, the lowest since Oct. 1. This represents a hefty 27% of CRBP's total available float though, and a whopping 26.4 times the average daily trading volume.

In the options pits, there is also some skepticism to be unwound. Looking at data from the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) shows CRBP stock's 10-day put/call volume ratio of 0.15 ranks in the 93rd percentile of its annual range. While this means purchased calls still outnumbered puts on an absolute basis, the high percentile indicates a much healthier-than-usual appetite for long CRBP puts over calls in the past two weeks.

Echoing this, the security's Schaeffer's put/call open interest ratio (SOIR) of 0.82 sits in the 100th percentile of its annual range, indicating that near-term traders have rarely been more put biased in the past 12 months. 

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI